Rediff-TV 📺

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.

Uploaded 2 hours ago

Duration: 0h 5m 30s

'14+ Anti-Obesity Drugs In The Pipeline'

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Uploaded by: Rediff Video Desk on Sat, 13 Dec 2025 10:08:44 +0530

Views: 7

Tags: '14+ Anti-Obesity Drugs In The Pipeline'

Share:          

Watch More Videos